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Abstract
Background:  The 5'-terminal cap structure plays an important role in many aspects of mRNA
metabolism. Capping enzymes encoded by viruses and pathogenic fungi are attractive targets for
specific inhibitors. There is a large body of experimental data on viral and cellular
methyltransferases (MTases) that carry out guanine-N7 (cap 0) methylation, including results of
extensive mutagenesis. However, a crystal structure is not available and cap 0 MTases are too
diverged from other MTases of known structure to allow straightforward homology-based
interpretation of these data.
Results:  We report a 3D model of cap 0 MTase, developed using sequence-to-structure threading
and comparative modeling based on coordinates of the glycine N-methyltransferase. Analysis of the
predicted structural features in the phylogenetic context of the cap 0 MTase family allows us to
rationalize most of the experimental data available and to propose potential binding sites. We
identified a case of correlated mutations in the cofactor-binding site of viral MTases that may be
important for the rational drug design. Furthermore, database searches and phylogenetic analysis
revealed a novel subfamily of hypothetical MTases from plants, distinct from "orthodox" cap 0
MTases.
Conclusions:  Computational methods were used to infer the evolutionary relationships and
predict the structure of Eukaryotic cap MTase. Identification of novel cap MTase homologs suggests
candidates for cloning and biochemical characterization, while the structural model will be useful
in designing new experiments to better understand the molecular function of cap MTases.
Background
Transcripts produced by RNA polymerase II are modi-
fied at their 5' end by the addition of a methylated 5'-ter-
minal cap structure m7G(5')ppp(5')N, which directs pre-
mRNA to the processing and transport pathways in the
cell nucleus and regulates both mRNA turnover and the
initiation of translation [1,2]. Cap is formed by a series of
three enzymatic reactions as follows: an RNA triphos-
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(c) 2001 Bujnicki et al, licensee BioMed Central Ltd.phatase (TPase) removes the γ -phosphate at the 5' end of
the transcript, a GTP:RNA guanylyltransferase (GTase)
adds a GMP residue to the 5' diphosphate end in a 5'-to-
5' orientation, and an RNA:guanine-N7 (m7G) methyl-
transferase (cap 0 MTase, for simplicity referred to here-
after as cap MTase) adds the methyl group to the guanine
[3]. Mutations in the TPase, GTase, or cap MTase of the
yeast capping apparatus that inhibit any of these activi-
ties are lethal in vivo [4,5,6]. The capping apparatus dif-
fers significantly in fungi, metazoans, protozoa and
viruses in respect to the evolutionary origin and struc-
ture of individual subunits and the subunit composition
of the proteins that carry the three activities [3]. Hence,
the capping enzymes encoded by viral, fungal and proto-
zoal pathogens are attractive targets for specific inhibi-
tors that would exert limited effect on the host enzyme.
The mechanisms and structures of cellular and viral cap-
ping enzymes have been extensively studied. The crystal
structures of the GTase from Chlorella virus PBVCV-1 [7]
and the TPase from yeast [8] have been solved and used
to guide extensive site-directed mutagenesis experi-
ments [9,10,11]. However, there are a few important gaps
in our understanding of capping enzymes. For instance,
there is a large body of mutagenesis data on cap MTase
[5,12,13,14,15,16]; however, its structure remains un-
known. Therefore, many important details of the cap
binding and m7G methyltransfer reaction mechanism re-
main unexplained.
Cap MTase belongs to the AdoMet-dependent MTase su-
perfamily [13], which contains numerous remotely relat-
ed families of DNA, RNA, protein, and small molecule-
modifying enzymes [17]. To date, three-dimensional
structures have been determined for more than a dozen
MTases. The common fold of the catalytic domain, which
bears the AdoMet binding site and the active site, has
been identified (reviewed in [18]). Despite low sequence
similarity, the catalytic domains of typical MTases dis-
play a common tertiary architecture, similar to the Ross-
mann-fold, but with a unique peripheral β -hairpin
structure instead of a typical right-handed β -α  turn [19].
Another characteristic feature of many MTase families is
the presence of an additional "variable" domain, which is
primarily responsible for substrate recognition and
binding. This domain has been initially characterized in
DNA:cytosine-C5 (m5C) MTases and dubbed TRD (for
target recognition domain). More recently, it was deter-
mined that the majority of TRDs of individual MTase
families are unrelated. They occur in different locations
in the primary structure of the protein and fold into dif-
ferent structures, suggesting that they have originated
from independent gene fusions ([18]. Nevertheless, it
has been shown that the TRDs of m5C MTases are struc-
turally similar, even though only several common resi-
dues could be delineated in their sequences that are
critical for stability of the hydrophobic core and interac-
tions of the TRD with the substrate. Moreover, based on
the sequence-to-structure threading, it has been predict-
ed that the TRDs of type I DNA MTases (a subclass of en-
zymes that modify adenine in DNA) share the common
fold with the TRD of m5C MTases [20]. This prediction
has been later supported by mutagenesis studies [21].
Therefore, aside from the structural and evolutionary di-
versity among TRDs, some MTase families may share
conserved homology in the catalytic and substrate bind-
ing domains, even though their sequences seem dissimi-
lar.
The prolonged unavailability of the atomic structure of
cap MTase prompted us to predict its structure and con-
struct a three-dimensional model, which is accompanied
by an evolutionary study. The results form this report
should aid in the interpretation and design of mutagene-
sis experiments and provide a framework for compara-
tive sequence-structure-function analysis of members of
the MTase family. Cap MTases exhibited limited similar-
ities to other MTases in the common AdoMet-binding re-
gion, and the substrate-binding site could not be
unambiguously identified, based on sequence analysis
and mutagenesis results [13]. Therefore, we resorted to
the sequence-to-structure threading method to find a
structural template for homology modeling. We report
here that cap MTases are related in structure to the gly-
cine N-MTase. In addition, we carried out extensive da-
tabase searches to identify novel genes that exhibit
homology to known cap MTases, which may encode yet
unidentified RNA modification enzymes.
Results and Discussion
Sequence analysis
Following a thorough search of the sequence databases,
sequences of genuine cap MTases displayed homology
with members of the cellular and viral cap MTase fami-
lies (15 and 8 sequences, respectively, with the pairwise
amino acid identity < 90%; Figure 1). No significant se-
quence similarity to the putative cap MTase domains
from alphaviruses, dsRNA viruses or yeast killer plas-
mids could be detected. Nevertheless, we noticed simi-
larities between the cellular cap MTases (BLAST e-value
< 10-4) and a putative protein F4F15.320 from Arabi-
dopsis thaliana, which lacked several conserved regions.
Reciprocal BLAST searches queried with At_F4F15.320
revealed that it is indeed closely related to cap MTases
(e-value < 10-5) and may represent a paralog of another
cap MTase-like protein from A. thaliana (At_F3H11.3),
which has been identified at earlier stages of the search.
Using the sequence of At_F4F15.320 as a query, we re-
trieved its close homologs from plants Glycine max
(combination of cDNA clones sd21c10.y2, sn79e11.y1 andsr53f01.y1) and Medicago truncatula (the sequence pre-
dicted from the cDNA clone pGVSN-24P11 was truncat-
ed at the C-terminus). These new sequences possessed
most features that were most common to "orthodox" cap
MTases, but missing from At_F4F15.320. We assumed
that the cDNA sequences from G. max and M. truncatula
were more likely to correspond to native proteins, while
the sequence of At_F4F15.320, deduced from the ge-
nomic data, might contain frameshifts and/or incorrect-
ly predicted intron/exon junctions. We corrected the
prediction of splice sites in At_F4F15.320 by compari-
sons of its DNA and protein sequences with those of its
newly identified homologs. All conserved elements could
be restored and the resulting sequence scored signifi-
Figure 1
Multiple alignment of the cap MTase family. Only the sequences, whose amino acid identity was lower than 90% were
included. Conserved motifs are labeled according to the nomenclature described for the AdoMet-dependent MTase super-
family [18]. Invariant residues are highlighted in black, conserved residues are highlighted in gray. Numbers show the size of
termini (unknown in preliminary sequences) omitted for clarity
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S.cerevisiae-6319713 138 RNLSPIIKLRNFNNAIKYMLIDKYTKPG---------DVVLELGCGKGGDLRKYGA-AGISQFIGIDISNASIQEAHKRYRSMRN------------LDYQVVLITGDCFG
S.pombe-7492203 109 RQFSPIIQLKRFNNWIKSVLIQKFAPHASDYP-----ILVLDMGCGKGGDLIKWDK-AGIDGYIGIDIAEVSVNQAKKRYREMHAS-------------FDALFYAGDCFS
C.albicans-5478247 167 RVNSPIYKMRNFNNAIKYILLGNWAKHNPEELD---LFSFLDLCCGKGGDLNKCQF-IGIDQYIGIDIADLSVKEAFERYTKQKARFR-HSNQNSNRYTFEACFATGDCFT
D.hansenii-12222044 ? RTKSPIYKLRNFNNAIKYILLGNWVKPNPDSNR---PTVILDLCCGKGGDLNKCEF-VSVDQYIGIDISDASIKEAFSRYSRNKARF(8)KERDTRRYNFEACFATGDCFS
D.melanogaster-7287871 100 RQKSKIFFMRNFNNWIKSQLINEYMSQIKQNKRMGDALRVLDMCCGKGGDLLKWEK-AAISHLICTDIAEVSVEQCQRRYQDILQRS----EKSKFANKFTAEFFACDSTL
M.musculus-12847332 153 RSQSRIFYLRNFNNWIKSILIGEILEKVRQRKT--RDITVLDLGCGKGGDLLKWRK-GRISRLVCADIADISMKQCQQRYEDMRCRR-------DNEHIFSAEFITADCSK
X.laevis-11399462 91 RSQSRIFHLRNFNNWMKSALIGEFVEKVQQRTR---NITVLDLGCGKGGDLLKWRK-GGISKLVCTDIADVSVKQCEQRYKDMKRKS-------RNERIFEAEFLTSDSTK
C.elegans-7496451 43 RKESRIFFMRNMNNWVKSQLINDAKQRVNDNGV--NNPRVLDLACGKGGDLKKWDI-AGAKDVVMADVADVSIQQAEERYKQMFGYK--------KNNIFTVQFIVADCTK
H.sapiens-4506567 164 RSQSRIFYLRNFNNWMKSVLIGEFLEKVRQKKK--RDITVLDLGCGKGGDLLKWKK-GRINKLVCTDIADVSVKQCQQRYEDMKNRR-------DSEYIFSAEFITADSSK
D.rerio-11051324+12356041 ? RNKSRIVYMRNFNNWLKSVLIAEILDKVRQKRR---EVTVLDLGCGKGGDLLKWKK-GRIDKLVCADIAAVSIEQCQQRYNDVRRRG------HPYDRTFSAEFITADCSR
G.intestinalis-7587724 ? RQISKIIPIRDFNNWAKSVLIKQYLVRGSGRKD----LSVMDMCSGRGGDLKKFSALGRVRYLACVDVSLESIVEAIMRYNAMVSGP-------NNRGLYLADFVWADVFE
T.brucei-5163883+5163883 ? STGKNRSILRHYNNWIKSVLISTSVSYLRSNNK(7)GMVVADLCSGRGGDLHKWRA-HQPKLLFMTDSCLEAVAEAAGRYSVSKGLSLRIVPQDKSSVGVVAYFTVCDVFD
L.major-5649335 ? LANEERSDLRRFNNWVKSVLLTTMAAAIRRALKPPAKLHVLDLCCGRGGDLLKWQH-IHPAFLFMTDASVECVAEAAARYSTSEGQSV--KVAKGKQKGFPAFFAVHDAFH
E.histolytica-11809175 ? RKYSEIVALKRYNNWVKACLIRKYIPEH---------SRVLDFCGGKGGDYIKFNQ-NSVRSVLTCDISGESLKDAEKRYKEREP-----------AFRFNLKTIKEDCFS
A.thaliana-F3H11.3-9294344 58 REASPIIHLKKLNNWIKSVLIQLYARPD---------DAVLDLACGKGGDLIKWDK-ARIGYYVGIDIAEGSIEDCRTRYNGDADHH-----QRRKKFSFPSRLLCGDCFE
Vaccinia virus-126817 557 TNKRTRGPLGILSNYVKTLLISMYCSKTFLDDS--NKRKVLAIDFGNGADLEKYFY-GEIALLVATDPDADAIARGNERYNKLNSGI----KTKYYKFDYIQETIRSDTFV
M.contagiosum_virus-9629022 662 TKRRVRGPLGVLSNYVKTLLISLYCSKTFFDNP--NKRKVLAVDFGNGADLEKYFY-GEIALLIATDPDARAIECGRERYNKLNSGN----KSKYYKFDYIQETIRSESFV
Fowlpox virus-9634816 562 LSNRVRGALGILSNFVKTLLISLYCSKTYLDNH--SKRKVLAIDFGNGADLEKYFY-GEIALMVATDPDDNAIETGKKRYNERNAGD----KSKYYKFNYIKETIRSETYV
Yaba virus-12085062 553 TNKRTRGPLGILSNYIKTLLISLYCSKTFLDNS--NKKKVLAIDFGNGADLEKYFY-GEISLLVATDPDSKAIERCNERYTKLNSGI----KSKYYKFNYIQETIRSSSYV
Rabbit fibroma virus-9633885 583 TNKRTRGPLGILSNYVKTLLISLYCSKTFLDNS--NKRKVLAIDFGNGADLEKYFY-GEISSLVATDPDKEAIGRCIERYNSLNSGI----KSKYYKFDYIQETIRSVTYV
A.m.entomopoxvirus-9964449 579 MNNTIRTSINILTNYLKTNGISMAISKLVTTLP---NRYVLSIDIGRGGDLTKYYY-VGITGMLGTDPDIFAIKEARDRYKKLQTISN--AQASIYKFDSLNMSILNDNYE
M.s.entomopoxvirus-9631502 568 NNQQQRPPLNIFTNLIKTEAISIAASKLCAEIP---NRHVLSIDIGRGGDINKYYY-IGISGMLGTDPDISALSEAQERYNSLQTRKR--VNSTVYKFSSLNISILDHDYL
Swine fever virus-450698 549 PSGMYFAGAKTGIYRAQTALISFIKQEIIQKIS--HQSWVIDLGIGKGQDLGRYLD-AGIRHLVGIDKDQTALAELIYRKFSHATTRQ--HKHATNIYVLHQDLAEPAKEI
A.thaliana-F4F15.320-11357775 5 VVSKPEQSHHRLFDFAKTAIINIFAHPY---------ATVCELYCGGAPETDKWEA-APIGHYIGIDTSSGIS---SVREAWESQRKN-----------YDVEFFEADPST
G.max-10234343+8669741+1023434 ? ----SQPTQQRLYDFAKMALINIFVHPY---------ATVCDLYCG-DADADKWAH-AQIGHYIGIDAPSSGI--DQMRETWETH-----------RKSYTAEFFELDPCT
M.truncatula-10700113 ? SESSSMSNHQRLYDFAKMALIKIFAHPY---------ATVCELYCGEASDAHKWLD-SQIANYIGIDVSSSAI--QQIRQSLGDN----------NNKSCTTHFFHLDPST
|<--motif X-->| |<-motif I->| |<-motif II->| |<motif III>|
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S.c. ESLGVAVEPFPDCRF-------PCDIVSTQFCLHYAFETEEKARRALLNVAKSLKIGGHFFGTIPDSEFIRYKLNKFPKEVEK-------------PSWGNSIYKVTFENNS----YQKNDYEFTSPYGQMYTYWLEDAI
S.p. ---SSINELLPPDQR-------KFDVVSLQFCMHYAFESEEKVRVLLGNVSKCLPRGGVMIGTIPNSDVIVKHIKMLKPGE---------------KEWGNDIYKVRFPESP--------PRSFRPPYGIQYYFYLEDAV
C.a. ---QFVPDILEPNFPGIIERAFPVDVVSAQFSLHYSFESEEKVRTLLTNVTRSLRSGGTFIGTIPSSDFIKAKIVDKHLQRDEKG----------KAKFGNSLYSVTFEKDP------PEDGVFRPAFGNKYNYWLKDAV
D.h. ---SSIPEILEPNFPGIIDGLFPVDCVSLQFAMHYAFETEEKVHQLLTNVTK ???
D.m. ---VRLRERYKDPSL-------QLNLVSCQFAFHYCFESMAQADCMMRNAAECLKPGGFFIATMPDAYEIIRRLRAAGPDA---------------RRFGNDVYSIEFDCET----------DPLPLFGAKYQFHLEGVV
M.m. ---ELLVEKFRDPEM-------YFDVCSCQFACHYSFESQVQADTMLRNACGRLNPGGYFIGTTPNSFELIRRLEASET-----------------ESFGNEIYTVKFQK-----------KGNYPLFGCKYDFNLEGVV
X.l. ---ELLSEKYIDPEI-------KFDICSCQFVYHYSFETYEQADTMLRNACERLCPGGFFIGTTPDGFELVKRLEASDT-----------------NSFGNDVYTVTFEK-----------KGKYPLFGCKYDFSLEEVV
C.e. ---ENLEDRIENKD--------PFDLVSCQFALHYSFVDEASARIFLKNAVGMLKPGGVFIGTLPDADRIVWSMRNGEN-----------------GQFANEVCKITYENVE------ELAEGKVPLFGAKFHFSLDEQV
H.s. ---ELLIDKFRDPQM-------CFDICSCQFVCHYSFESYEQADMMLRNACERLSPGGYFIGTTPNSFELIRRLEASET-----------------ESFGNEIYTVKFQK-----------KGDYPLFGCKYDFNLEGVV
D.r. ---ELLSEKLQDPEL-------QFDVCSCQVVYHYCFESESQADTMLRNACERLRPGGFFIGTTPDAYELVKRLEESDS-----------------NSFGNEVFSVTFQK-----------KGEYPLFGCQYDFSLEGVV
G.i. ---TALSKHFIPHKKG-----LRFDMISCQFALHYAFESEARARILFQNIRDCLSNEGSFIAIFASKEIILSRLEAAGYSWPSAAIP---------PSIGNGLYSVRFTEPFR-------ADPHNPNYGVKYYFELEEAI
T.b. ---EALFEKIIDPGG-------KLDVVSCQFSIHYGCSNEERVRVFLSAVSSTLKSGGIFIGTTVSDTELLRRLRQYGT------------------TFGNGIYTVRFPTD----------AVPNDSFGVEYSVSFESSV
L.m. -AASGLREDLLKRG--------PFQLASCQFSMHYGCRSQESMRYFVKAIADSLVPHGRFVGTTVSDVELLYRAKEHGA------------------EFGNDVYGVRFGAEAFAQLQSANFEPAALSFGVPYAATVERSV
E.h. ---SELLNKIPSNS--------SFEAVSCQFAIHYSFETKERAYQAIFNLTKYLRKGGLFVGTTVNAYRVVKKLRTVPG-----------------NKFGNELFTIRFDEQFD--------KENIPTYGAKYYFELKDAI
A.t. ---VELDKILEEDA--------PFDICSCQFAMHYSWTTEARARRALANVSALLRPGGVFIGTMPDANVIIKKLREAEG-----------------LEIGNSVYWIRFGEEYS-----QKKFKSSSPFGIEYVFHLEDAV
G.m. ??? NVIIKKLREAEG-----------------LTFGNRVYWVRFDEEFS-----DKKFKSSSPFGIKYTYHLEDAV
VacV ---SSVREVFYFG---------KFNIIDWQFAIHYSFHPRHYA-TVMNNLSELTASGGKVLITTMDGDKLSKLTDKKTFIIHK-----------NLPSSENYMSVEKIAD----------------DRIVVYNPST--MS
MCV ---ASVREVFYFG---------KFDIVDWQFAIHYSFHPRHYA-TVMRNLAELTASGCRVLITTVDGDFLATLTRKRSFVIHR-----------DLPEPENYISFEKLDS----------------EHVLVYNPST--MA
FV ---SSIRQVLYFE---------KFSLVDWQFAIHYSFHPKHYSTIMTNLQ-ELTESGCKVLITTMDGDYLDTLKEKKKFIIRK-----------LLPETENYLSIEKIDD----------------DKVLVYNPSS--MS
YV ---SSVREVFFFG---------KFDIIDWQFAIHYSFHKKHYSTIMKNLT-ELTASGGKVLITTMDGDKLYNLKDKKTFIIHK-----------SLPSSENYMSVEKINS----------------EQILVYNPSS--MS
RFV ---SSVREVFFFG---------KFDLVDWQFAIHYSFHPKHYA-TVMNNLTELTASGGKVLITTMDGDLLSQLTDKKTFVIHK-----------NLPSSENYMSVEKIHE----------------DQILVYNPSS--MS
AMEV N---EIKNKFMTHHKIQ-----YFGVIEWQLAIHYSYNNNTKD-MILLKLKNLSNDGTKVIITCLDGDEITNRLN----------------------ENPNLIYNIQPGIT-------YKISKISDDKISVLYNAT--MT
MSEV N---KVKSTYMTQQKIK-----YFGLIEWQMAIHYSYNVDTKN-KILNILKNLSTDGTKVIITCLNGNKIKNLLI----------------------NNQNIKYKIQDNIY-------YNISKVNDDKIKVLYDAT--MT
ASFV S--EKVHQIYGFPKE-------GASSIVSNLFIHYLMKNSQQVENLAVLCHKLLQPGGMVWFTTMLGERVLELLHENRIELNE-----------VWEARENEVVKFAIKRLFK-----EDILQETGQEIGVLLPFS--NG
A.t. ---DDFEIQLQKKLEQ-------ADLVSCWRHLQVCFETEESARRLLTNVACLLKPGGYFFGITPDSSTIWAKYQKNVEAYHNRSG-AKPNVFPNYIRSESYMITFELEE------------EKFPLFGKRYQLKFSGDN
G.m. ---ENIETHLEEKTN-------MTDVVCCLQHLQLCFDTEEKARKLLHNVSSLLKPGGYFLGITPDSSTIWAKYQRNVEAYHNKSSSMKPNIVPNCIRTENYMITFEVEE------------EKFPLFGKKYQLKFANDV
M.t. ---ESIEIRLEDKTN-------TVDFVCCLQHLQLCFETEEKARRLLQNVSSLLKPGGYFLGITPDSSTIWAKYQKNVESYHNRSSSMKPNIVPNCIRTENYTIAFEVEE------------EKFPLFGKKYQLKFANDV
|<-motif IV->| |<motif V>| |<-motif VI->|
350 360 370 380 390 400 410 420
..|....|....|....|....|... .|....|....|.. ..|....|....|....|. ...|....|....|....|....
S.c. DNVPEYVVPFETLRSLADEYGLELVS-QMPFNKFFVQEIPK----------------WIERFSPKMREGLQRSDGR-------------------------------YGVEGDEKEAASYFYTMFAFRKV 11
S.p. TDVPEYVVPFEAFRAVAEGYNLELIW-VKPFLDILNEEKNS---------------ETYGPLMDRMKVVDNEGHR---------------------------------GIGGQEKEAAGFYLAFAFEKRG 1
C.a. DNVPEYVVPFETLRSLCEEYDLVLKY-KKSFTDIFNQEIPK----------------YFSKLNKNLIDGMKRSDGK-------------------------------YGAEGDEKEAVAFYIGFVFEKV- 0
D.m. D-CPEFLVHFPTLVKLGRKYGLQLLK-RSTFADYYKENLHHG-----------------RHLLQRMSGLESVQPQR-----CENDEEFAHVSN----FQGAQRSRSVGTLSKSEWEAATLYLVCAFKKCK 14
M.m. D-VPEFLVYFPLLTEMAKKYNMKLIY-KKTFLEFYEEKIKN---------------NENKMLLKRMQALEQYPAHENSKLASEKVGDYTHAAEY---LKKSQVRLPLGTLSKSEWEATSIYLVFAFEKQQ 0
X.l. N-VPEFLVYFPVLVEMAKKYQMKLIY-KKTFREFFEEKVKN---------------DEQKMLLKRMKALESYPAAPNTKLVSGRTEDYEHAQKM---VENGQIKLPLGTLSKSEWDATSIYLLFAFEKQA 0
C.e. N-CPEFLAYFPLVKHLLEELDMELLF-VHNFAEAINKWLE-----------------PGRRLLESMTGLETYPNEKLSGKSDDEYLEAKAKLDA---FPEDERIKTMGTLSKSEWEAICMYLVFGFRKKK 45
H.s. D-VPEFLVYFPLLNEMAKKYNMKLVY-KKTFLEFYEEKIKN---------------NENKMLLKRMQALEPYPANESSKLVSEKVDDYEHAAKY---MKNSQVRLPLGTLSKSEWEATSIYLVFAFEKQQ 0
D.r. N-VPEFLVYFPLFVEMAKKYNMRLVY-KKTFKEFFEEKVKDG---------------KNKDLMQWMQALEQYPPDERGQLSSSGPGEYDHAKRK---AADPAXRRPLGTLSKSEWEATSI---------- ?
G.i. DNIPEYFVDFENIRTLCKEFGLTIKKHFATLSDFYNEYFNLHPEPSETEFFKRMLKNTGKYLTQEIQRGENLENSCSDFFDDASEEEQPAQLAEGTVVTEVVDVKALTDLPAKYLEVINIYQAVVIGHAQ 44
T.b. SEMPEYLVPWNRFVNLCGAYNLQLVE-SFGFVEYGDMHYNS---------------ALGQELRDASMNGGRRDSDGHLR----------------------------LRLSPDEAEAAGLFRTFLFVKI- ?
L.m. QDMTEYVVPWDAFVALCAEHQLKLVL-EDNFIHYYGQHKDT---------------EAGKAMTLEQRRKRHNDGDVVD-----------------------------CPLSPSEQAAVGLYRLFVFEKTK 10
E.h. DNLPEYLIPFCEFQKICEEHGLKLIG-FWDFHQFYREWIKFQ---------------EYNELLDKMGKIDYMP--------------------------------------NNQWEIISYYCAFVFQKVR 0
A.t. D-CPEWIVPFNVFKSLAEEYDLELVF-VKNSHEFVHEYMKKP---------------EFVELMRRLGALGDGSNDQ-------------------------------STLSADEWEAAYLYLSFVLRKRG 27
G.m. D-CPEWIVPFHVFKSLAEENDFELVF-AKNSHEFVHEYMKKP---------------EFVELMRRLGALGDGNQDQ-------------------------------STLSADEWEAAYLYMSFVLRKRG 28
VacV TPMTEYIIKKNDIVRVFNEYGFVLVD-NVDFATIIERSKKFI--------------NGASTMEDRPSTRNFFELNRGAI----------------------------KCEGLDVEDLLSYYVVYVFSKR- 0
MCV KPMVEYIVRKQALVRVFGEYGFVLVD-HVDFHTVVHRSRAFI--------------DGVAQMESRTSTKNFFELNRAAL---------------------------QSCRGLDVEELLQYYVVYVFAKR- 0
FV KPMAEYIVRRDTLIRVFREYKFKLID-SCNFKTIIDRNISFI--------------NGVSRLESRGSTKNFFELNRKAL---------------------------EECNDTDVLELLSHYMVYVFSKEV 0
YV KPMEEYIVKKLDIVRIFSEYGFELID-NVNFDTVINRSKKFI--------------NCVSKMEERQSTKNFFELNREAL----------------------------KFDVLDVEELLSYYVVYVFSKR- 0
RFV RPMQEYIVKRVNLTKIFSEYGFELID-CVHFDTIIERSKRFI--------------NSVSKMEERKSTKNFFELNREAL----------------------------KHEGTDIDDLLRYYIVYVFSKR- 0
AMEV EWLEEYIIT-DKIIDDFAMYNFILSD-VCKFDDIFKYNSDKS--------------VEVLSNFLRKSTKKFYNDIKNDK---------------------------NIYNNDDIKKIMSLFKVYTFVYSS 3
MSEV TWLEEYLIY-DTIIEDFNKYNFILDD-MFEFKDIYNNDAMLV--------------LKTNSLFPRKATSVFYKNILNQN-----------------------------TKDNQVLELMNLFKVYIFKYKS 4
ASFV DFYNEYLVNTAFLIKIFKHHGFSLVQ-MQSFKDWIPEFQTFS--------------KTLYKI-----------------------------------------------LTEADKTWTSLFGFICLRKN- 0
A.t. ASEDHCLVHFPSLIRLAREAGLEFVE-IQSLTDFYDDNRFEVSHTCRFSIFYHELLAQFASLL-MNAGPNFVDPR--------------------------------GKLLPRAFDLLGLYATFIFQKPD 106
G.m. SAETYCLVHFPSFIRLAREAGLEYVE-IQNLTEFYDDNRAQ------------------LAGPVTHYVPNLLDPR--------------------------------GRLLPRSYDALGLYTTFIFQKPD ?
|<-motif VII->| |<-motif VIII->|cantly higher in BLAST searches against genuine cap
MTases (e-values < 10-15).
The sequences of viral, cellular cap MTases and the new-
ly identified subfamily of putative MTases from higher
plants exhibited relatively high similarity in their N-ter-
minus. However, after different substitution matrices,
gap opening and extension penalties were used in both
PSI-BLAST and CLUSTALX, their C-termini were found
to align poorly, and we observed substantial variation in
the multiple sequence alignment in this region. There-
fore, even the construction of a global alignment, includ-
ing known viral and cellular cap MTases, presented
considerable challenges. Since the sequences within the
subfamilies showed high similarity and could be aligned
over their entire length, we resorted to profile-to-profile
alignment using FFAS, which was proven superior to
pairwise or sequence-to-profile alignments [22]. The re-
sults revealed that all three subfamilies shared homology
not only at the N-terminus, but also at several moderate-
ly conserved regions at the C-terminus, separated by re-
gions of high variability. Remarkably, the pattern of the
secondary structures predicted for individual sub-
families using JPRED agreed very well with the align-
ment reported by FFAS. For example, not only were the
number and order of predicted helices and strands the
same, but also aligned well, showing strong correlation
with the aforementioned blocks of moderately conserved
sequence (the final alignment is shown in Figure 1).
To improve the multiple sequence alignment and to pro-
vide a structural framework for the interpretation of ex-
perimental studies and phylogenetic analysis, we
attempted to predict the tertiary structure of cap MTase
using sequence-to-structure threading and homology
modeling. The rationale behind this approach is that
most of the alignment errors that are undetectable at the
level of primary and secondary structure would manifest
themselves in the model. They could be identified and
corrected by computer software for the evaluation of ter-
tiary structures, followed by the analysis of graphic rep-
resentations with a trained eye. We submitted sequences
of several members of each subfamily, as well as artificial
"consensus" sequences that represented the individual
subfamilies or the entire family to the MetaServer ( [ht-
tp://bioinfo.pl/meta] ), which combines several pro-
grams for prediction of secondary structure, solvent
accessibility and fold recognition (i.e. detection of the
known structure) that are most compatible with the que-
ry sequence (see Materials and Methods). A similar strat-
egy based on only one fold recognition algorithm was
recently applied for analysis of heterotrimeric PCNA
family members [23].
All fold recognition algorithms systematically reported
the AdoMet-dependent methyltransferase fold and par-
ticularly the glycine N-methyltransferase (GNMT) struc-
ture [24] as the best modeling template for members of
the cap MTase family, regardless of which sequence was
used as a query (data not shown). Importantly, while
most of the MTase structures showed compatibility with
the cap MTase sequence only in their N-terminal do-
mains, which span MTase motifs X and I-VI, the align-
ments with the GNMT structure were frequently
reported to span the full length of both the target and the
template. Moreover, the models based on these align-
ments formed compact, mutually superimposable struc-
tures. The protein arginine MTase Hmt1 [25] also
produced long alignments; however, these were incon-
sistent with one another and resulted in models with
largely misfolded C-termini (data not shown). Therefore,
the GNMT structure was chosen as the main modeling
template along with other MTase structures serving as
guides in modeling of the variable regions, such as those
with relatively large insertions and deletions that result
in truncation or extension of secondary structural ele-
ments. The S. cerevisiae cap MTase (ScABD1 protein)
was chosen as the representative modeling target since it
is well-characterized experimentally [5,13,16], and it
lacks certain non-conserved insertions that are present
in the cap MTase from C. albicans or higher Eukaryota
(Figure 1). The modeling posed a formidable challenge
because of the variability between alternative target-
template alignments that were reported by different
servers. Hence, our modeling strategy followed a modi-
fied version of "multiple models" approach [26] and em-
ployed a variety of alternative models based on
alignments with several templates evaluated by several
different criteria (see Materials and Methods). Refine-
ment of the model was done in parallel with refinement
of the multiple sequence alignment and involved addi-
tional threading and modeling for updated consensus se-
quences. This procedure was utilized until the final
model could not be further improved. The final target-
template alignment is shown in Figure 2.
Sequence conservation and evolutionary relationships in 
the cap MTase family
Analysis of the multiple sequence alignment revealed
amino acid residues that are conserved among all or
most of the individual family members as well as some
differences between the three subfamilies (Figure 1). To-
gether with the unrooted phylogenetic tree, which was
calculated from this alignment (Figure 3), these results
demonstrate that viral and cellular cap MTases and the
newly identified proteins from green plants originate
from three phylogenetically distinct lineages. It should
be noted that sequences obtained from preliminary data
and cDNA clones may contain errors that can influencethe outcome of the comparative analysis. The fact that
several sequences are truncated could have affected the
calculated phylogenetic distances (i.e. the length of the
branches). For instance, an elongated C-terminus of pu-
tative MTase from Giardia intestinalis (low-pass HTG
sequence MJ2197) may be an artifact, for it shows little
similarity to yeast MTases and could not be unambigu-
ously threaded onto the GNMT structure. However, we
believe that the predicted topology of the branching pat-
tern is correct because it remained unchanged after the
incomplete or preliminary sequences were removed. The
topology is also strongly supported by bootstrap analy-
sis, and the phylogenetic groups correlate well with the
presence of sequence signatures that can be regarded as
synapomorphies (shared features derived from a com-
mon ancestor). For instance, the MTases from yeast pos-
sess a unique insertion close to the C-terminus.
Another peculiarity emerging from the alignment is the
mosaic character of similarity of the new plant MTase
family to viral and "orthodox" cellular enzymes. For in-
stance, the "ENYM" patch (corresponding to aa 306-309
in ScABD1) is conserved in viral MTases and in the newly
identified proteins, but absent from "orthodox" cellular
enzymes, and the "PLFGXKY" patch (corresponding to
aa 328-334 in ScABD1) is common to all cellular en-
zymes, but absent from viral MTases (Figure 1). It should
be noted however that viral and "orthodox" cellular en-
zymes are mutually similar in many regions that are oth-
erwise considerably diverged in the plant MTases, which
suggest that the latter are more ancient. We could not
predict with confidence a potential function for the sub-
family of plant MTases. It is possible that they represent
genuine cap MTases from the yet unidentified plant vi-
ruses or small nuclear RNA capping enzymes. Their
function remains to be determined experimentally.
General features of the three-dimensional model of S. cer-
evisiae cap MTase
As expected, the model of S. cerevisiae cap MTase
(ScABD1) is similar to the GNMT template and displays
the essential features of the typical AdoMet-dependent
MTase fold [18,19] (Figure 4). All insertions and dele-
tions (indels) localize primarily to surface loop struc-
tures of GNMT and do not disrupt the core elements.
Modeling of indels present in other family members re-
sults also in reasonably folded structures (data not
shown), indicating that the target-template alignment is
well optimized. Only several insertions longer than 20
amino acid residues (including the region E379-K409 in
ScABD1) that mapped to solvent-exposed regions were
not modeled because the present methodology does not
allow for conformational prediction of such large frag-
ments of the polypeptide chain or of their packing
against the common core.
Figure 2
Alignment of the structural template GNMT and the ScABD1 sequence. Identical residues are highlighted. Second-
ary structure elements detected in GNMT (virtually identical to those in the ScABD1 model) are shown as cylinders (α -heli-
ces) and arrows (β -strands).
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The phylogenetic tree of the cap MTase family. The numbers at the nodes indicate the statistical support of the branch-
ing order by the bootstrap criterion. The nodes with bootstrap support < 50% are shown as unresolved. The bar at the bot-
tom of the phylogram indicates the evolutionary distance, to which the branch lengths are scaled based on the estimated
divergence.The N-terminal 139 residues and the C-terminal 12 resi-
dues of ScABD1 were not included in the model. The
present C-terminus maps to the "back" of the cap MTase,
while the N-terminus protrudes outside its AdoMet-
binding/catalytic face. Shuman and coworkers carried
out deletion mutagenesis of ScABD1 and reported that
mutants lacking the 130 N-terminal residues or the 10 C-
terminal residues were fully active, whereas the activity
of a mutant lacking 143 N-terminal residues was reduced
to ∼  5% of that of the wild type ScABD1 [13]. The GNMT
template lacks the counterpart of the C-terminal 12 resi-
dues of ScABD1 [24]. This region is not conserved among
other AdoMet-dependent MTases [18], suggesting it is
dispensable for the stability of the MTase core. A C-ter-
minal deletion of 55 amino acids (residues 381-436) was
lethal [5]. According to our model this region encom-
passes the antiparallel β -strand that takes part in forma-
tion of the hydrophobic core and its loss would
destabilize the MTase structure.
In GNMT, which unlike most MTases is a tetrameric en-
zyme, the N-terminus is swapped between the subunits
and acts as a cork to the active site entrance [24]. In the
enzymatically active "open" conformation of GNMT, the
residues 1-40 are disordered. It has been suggested that
this region takes part in auto-inhibitory and forced prod-
uct release mechanisms [27]. As discussed by Takusa-
gawa and coworkers [27], the flexible loops of many
enzymes can stabilize the active site when ligands bind.
We hypothesize that the corresponding region to the N-
terminus of N150 in ScABD1 may form a conformation-
ally variable structure that affects the binding of the lig-
ands. Analysis of the molecular surface of the model
(Figure 5) reveals two large pockets that are predicted to
serve as the cofactor- and guanine-binding sites and a
neighboring positively charged area that may bind the
phosphate groups of the mRNA chain. The predicted
flexible N-terminus is located at the border of the puta-
tive mRNA-binding patch, "below" the two pockets.
Thus, participation of this region in regulation of sub-
strate binding and catalysis seems plausible.
Structure-based analysis of site-directed mutagenesis re-
sults
Alanine scanning mutagenesis of the cofactor-binding
region in S. cerevisiae and human cap MTases revealed
that of all residues of the sequence patch 168-VLELGCG-
KGGDLRKY-182 (motif I) only E170, G174, and D178 are
essential [14]. The data for C. albicans suggest that the
counterparts of L169 and L179 in ScABD1 (L204 and
L214 in CaABD1) are also indispensable for both in vitro
and  in vivo activity of the enzyme. In ScABD1, L179
packs against the side chain of E170, while in CaABD1
L214 packs against the shorter side chain of D205, sug-
gesting that the L214A substitution creates a larger cavity
in the hydrophobic core of CaABD1 that may perturb the
overall architecture of the AdoMet-binding site. The
E170D mutant of ScABD1 was viable [16], suggesting
that a carboxylate is essential at this position. Indeed, an
acidic residue is present at this position in most AdoMet-
Figure 4
A cartoon diagram of the modeled ScABD1 protein. The selected functionally important residues discussed in the text
are shown in wireframe representation and labeled.dependent MTases [18]. In the recently solved high-res-
olution structure of rRNA:2'-O-ribose MTase RrmJ, a
D57 residue present at this position coordinates the ni-
trogen atom of AdoMet via an ordered water molecule
[28]. However, this carboxylate is replaced by Ala or Ser
in cap MTases from all viruses except for ASFV (Figure
1). Notably, all viral MTases (again, except for ASFV)
possess an Asp residue in the position corresponding to
G172 in ScABD1. Modeling suggests that in viral MTases
and in the ScABD1 double mutants E170A G172D, the
carboxylate would make an equivalent, direct contact to
the AdoMet moiety (data not shown), which suggests a
Figure 5
Crossed stereoview of the electrostatic potential mapped onto the molecular surface of ScABD1. The values of
surface potentials are expressed as a spectrum ranging from -10 kT/e (deep red) to +10 kT/e (deep blue). The guanine moiety
(docked by hand only to help visualize the size of the "molecular basket") and AdoMet are shown in wireframe representation.textbook case of correlated mutations. This important
difference between cellular and viral cap MTases may be
utilized in rational drug design.
Alanine substitution of the other two residues in the
AdoMet-binding region, i.e. D194 (in motif II) and R206
(in motif III) abrogates the enzyme's activity; however,
conservative substitutions at these positions that allow
retention of the charged functional groups are tolerated
[13]. According to our model, the carboxylate D194 di-
rectly coordinates the ribose oxygens while the role of
R206 is less clear. It might participate in the binding of
phosphate groups of the nascent RNA chain, for it forms
part of a large basic patch at the protein surface (Figure
5). However, this hypothesis remains to be tested exper-
imentally. Other polar residues that may be a part of this
predicted binding patch include R147, N150, N151, K154,
and Y155. All of these residues have been individually
mutated to Ala without an observed loss of activity in
vivo [16]. It is conceivable that non-specific binding of
mRNA depends on electrostatic interactions that are not
dependent on the presence of the individual functional
groups in the protein. It would be interesting to test if
such simultaneous mutagenesis of the above residues
can significantly lower the affinity of the protein to the
mRNA substrate. Another group of non-essential resi-
dues includes E202, Y207, R208, Y215, and D223. They
are not universally conserved in the cap MTase family
and are localized in the variable edge region of the Ross-
mann-fold-like AdoMet-binding subdomain. In our
model, only D223 is predicted to form a contact with the
adenine ring of the AdoMet moiety. It would be interest-
ing to test if the in vitro AdoMet-binding activity of cap
MTase is influenced by the D223A mutation.
Alanine scanning mutagenesis identified only three resi-
dues in the central and C-terminal part of ScABD1 that
are essential for catalysis [5,16]. In our model Y254 is
buried in a hydrophobic core and F256 stacks with the
adenine ring of AdoMet in a manner similar to W117 in
the GNMT structure [27], which explains why hydropho-
bic residues at these positions are required for the cap
MTase activity. According to our model, Y330 is located
in the lid subdomain where it forms the external wall of
the "molecular basket". A bulky hydrophobic residue is
present at this position in all cap MTases (Figure 1).
Among the residues from the central and C-terminal part
of ScABD1 that were found to be nonessential [5,13,16],
D244, G276, G277, E287, E361, Y362, G363, L366, V367,
and K423 are not located at the protein surface near any
of the predicted binding sites, and their substitution
should not influence the structure or function of cap
MTase. Residues T282, P284, W305, and Y416 form a
cluster at the surface of the catalytic domain near the en-
trance to the "molecular basket" where the substrate
might bind. However, it is not apparent from the mod-
eled structure alone if they can take part in catalysis or
binding; therefore, their localization in the model is not
inconsistent with the experimental data. W383, E385,
E408, and E410 map to the loop between the C-terminal
β -strands, which has not been included in the present
model because its structure could not be predicted with
confidence. On the other hand, F279, F419, and F421 are
in the hydrophobic core of the catalytic domain. Y348,
V349, and V350 form part of an interface between the
"lid" subdomain and the catalytic domain, and F314 is lo-
cated in the lid subdomain on the inside of the "molecu-
lar basket". No straightforward explanation is offered by
the current model to rationalize why substitutions of
conserved residues at these important locations do not
have any influence on ScABD1 activity in vivo. It is pos-
sible that introducing cavities at these positions in the
protein core may slightly destabilize the structure but
not disrupt the overall fold, which allows cap MTase to
retain its activity. We suggest that introducing polar or
charged side chains at these positions (for instance Arg)
should disrupt the protein core and render the enzyme
inactive.
Structure-based prediction of guanine-binding residues
In GNMT, the additional "S" domain, composed of a
three-stranded β -sheet, forms the wall of a large "molec-
ular basket" structure, which may accommodate a varie-
ty of small molecules, including AdoMet,
tetrahydrofolate and polycyclic aromatic hydrocarbon
molecules, such as benzopyrene (reviewed in [29]). Ac-
cording to the secondary structure prediction and
threading algorithms, cap MTases also possess a similar
structure that is a good candidate for a target-binding
site. Therefore, we looked for conserved residues that
could correspond to the guanine-binding site at the inner
walls of the "molecular basket" of the cap MTase model.
To our knowledge, all structurally characterized MTases,
which modify bases in nucleic acids and do not employ
covalent bond formation with the target, use aromatic or
aliphatic side chains to bind the base to be methylated
via hydrophobic interactions with the heterocycle for sta-
bilization in the active site. Examples of such MTases, for
which the structure of the active site was determined ex-
perimentally or predicted from sequence analysis, in-
clude enzymes generating N6-methyladenine in DNA
and RNA (reviewed in [30]), N4-methylcytosine in DNA
[31], and N2-guanine in RNA [32]. On the other hand,
various polar residues could be implicated in specific
contacts to the hydrophilic edge of the base as it has been
proposed for DNA amino-MTases [31].
We have identified several conserved residues that local-
ize to the inner surface of the "basket", which have notyet been tested whether they are important for the cata-
lytic activity of ScABD1. They include the invariant Asn
residue (N307 in ScABD1), which may hydrogen bond to
the O6 atom, the N2 amino group of the target guanine
and the aromatic residue (Y310 in ScABD1), which could
be involved in stacking interactions with the aromatic
heterocycle. The aromatic residue is present at this posi-
tion only in proteins from entomopoxviruses and in "or-
thodox" cellular enzymes (Figure 1), except for the
protein from C. elegans, which is substituted by a Cys
residue that is quite big and hydrophobic and may be in-
volved in van der Waals interactions with the target gua-
nine. Interestingly, in all sequences from viruses (except
for ASFV) and in putative proteins from higher plants, a
Tyr residue is present at the position corresponding to
S308 in ScABD1. Modeling of viral MTases and in silico
mutagenesis of ScABD1 suggests that aromatic residues
located in these two alternative positions could have
their side chains oriented in a similar manner (data not
shown), arguing for a similar case of correlated muta-
tions as described previously for a carboxylate residue
involved in AdoMet binding (see above).
We considered several candidates for the possible sec-
ond aromatic residue localized in the vicinity of the con-
served N307, and the methyl group of AdoMet. F250A,
W305A, and Y416A mutants were shown to be functional
in vivo [16]. However, it would be interesting to test
whether mutations at these positions influence binding
of the substrate in vitro. F149 in ScABD1, which has not
been analyzed by mutagenesis, is located further away
from the predicted substrate-binding site (7.5 Å from
N307) and is conserved only in cellular proteins. Never-
theless, the conformation of the N-terminus of the tem-
plate GNMT structure changes between the closed and
open forms of the protein [27]. As we proposed (see
above), the corresponding region may be mobile also in
the ScABD1 structure, thus F149 could be relocated upon
target binding. It cannot be ruled out that the mecha-
nism of cap binding by cap 0 MTases is different from
that of cap 1 MTase from vaccinia virus [33], or that tar-
get base binding by nucleic acid amino-MTases does not
necessarily employ stacking of the guanine base between
two aromatic sidechains. Another possibility remains
that the side chains involved in guanine binding are
poorly conserved between the subfamilies, or the corre-
sponding alanine mutants retain their function in vivo
[16] and a more sensitive approach is required to analyze
the influence of mutations on the efficiency of catalysis.
Conclusions
In this report, we used computational methods to infer
the evolutionary relationships and predict the structure
of cap MTase. A tertiary model has been built for the Eu-
karyotic enzyme and used to interpret the available mu-
tation data and guide the comparative sequence analysis.
We propose that cap MTases share the catalytic domain
and the "S" domain with glycine N-MTases, which raises
the possibility that these two families of N-MTases are
relatively closely related. Moreover, we have identified a
novel family of putative MTases that are specific to green
plants and share structure and mechanism with cap
MTases. Therefore, the alignment presented in this work
will be a good starting point for further analysis of other
N-MTase subfamilies that may share the "molecular bas-
ket" structure. Our analysis of the AdoMet-binding site
in cap MTases, combined with evolutionary considera-
tions, highlighted a case of correlated mutation in viral
enzymes, which may be important for design of specific
antivirals. We also used the model to predict the guanine
binding site and identify conserved residues that may
serve catalytic or structural function, which can be tested
by site-directed mutagenesis. A putative non-specific
mRNA binding patch was also proposed. Prior to the ex-
perimental solution of the structure of cap MTase, our
model will be useful in designing new experiments to
better understand the molecular function of cap MTases,
whereas the identification of a novel family of genes will
aid in identifying candidates for cloning and biochemical
characterization. We hope that the prediction of numer-
ous structural and functional features presented in this
paper will advance these studies.
Materials and Methods
Sequence analysis
PSI-BLAST [34] and FFAS [22] algorithms were used to
search the non-redundant version of current sequence
databases (nr) and the publicly available complete and
incomplete genome sequences via the Gene Relational
DataBase (GRDB) ( [http://grdb.bioinfo.pl] ). The EST
(expressed sequence tag), STS (sequence-tagged site),
HTG (high throughput genomic) and GSS (genome sur-
vey sequence) divisions of the GenBank database [35]
were searched at NCBI ( [http://www.ncbi.nlm.nih.gov/
] ) using TBLASTN [36]. Fragments of sequences were
assembled into partial ORFs using the sequences of gen-
uine cap MTases as guides; the predicted splicing sites
were verified in reciprocal BLAST searches against the
database comprising sequences of cap MTase homologs.
All sequences were subsequently realigned using the
CLUSTALX program [37] to the degapped profiles ob-
tained from the multiple sequence alignments reported
by BLAST. Manual adjustments were introduced based
on the BLAST pairwise comparison, secondary structure
prediction, threading results, and finally, superposition
of modeled structures (see below).
Phylogenetic analysis
The number of amino acid replacements per sequence
position in the alignment was estimated using the JTT[38] model. The sampling variance of the distance values
was estimated from 1000 bootstrap resamplings of the
alignment columns. The evolutionary inference was per-
formed according to the neighbor-joining method of Sai-
tou and Nei [39]. Multiple runs were conducted with
randomized sequence input order to avoid the tree being
caught in a local statistical minimum.
Structure prediction
In search for structurally characterized homologs of cap
MTase we used the MetaServer available at http://bioin-
fo.pl/meta/ [40], which uses fold recognition methods
such as FFAS [22], 3DPSSM [41], BIOINBGU [42], Gen-
Threader [43], SAM-T99 [44], FUGUE ( [http://www-
cryst.bioc.cam.ac.uk/~fugue/] ), and 123D+ [45]. These
methods "thread" the query sequence (the target) onto
every fold in libraries of structures (templates) and re-
turn 10 alignments that scored best according to the cri-
terion of compatibility, which is specific for a given
algorithm. The results are collected by the MetaServer
and submitted to the Pcons neural network (J.Lund-
strom, L.Rychlewski, J.M.Bujnicki, and A.Eloffson,
manuscript submitted), which compares the models and
the associated scores and produces a ranking of poten-
tially best predictions. Pcons differs from other "consen-
sus" methods since it predicts the quality of a model and
not simply if a correct fold is recognized or not. This is es-
pecially advantageous in cases where several alternative
folds are reported or if the correct fold is reported by
most servers, but the alignments differ, or if one needs to
choose the best template from several similar structures.
In addition to prediction of the three-dimensional fold,
the MetaServer displays the independently predicted
secondary structure according to PSIPRED [46], SAM -
T99 [44], and JPRED [47], with the latter server report-
ing also the predicted solvent accessibility profile. These
predictions were compared with secondary structures
and solvent accessibility calculated directly from the
threading-based models of cap MTases.
Modeling
Homology modeling was carried out following a modi-
fied version of the "multiple models" approach [26]. Us-
ing the SWISS-MODEL/PROMOD II server [48] and the
GROMOS forcefield for energy minimization [49] we
generated a set of preliminary models based on thread-
ing-derived pairwise target-template alignments ob-
tained from the MetaServer. The preliminary models
were then superimposed using SWISS-PDB VIEWER
[50] and the best fragments were merged into the final
structure. The choice of fragments was based on the eval-
uation of their stereochemical and energetic parameters
by WHATCHECK [51] and PROSA II software embedded
within PROMOD II [52], consensus between the individ-
ual methods, agreement with the independently predict-
ed pattern of secondary structures and solvent
accessibility (see above).
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